National Research Corp Aktie
Finanztrends
Deine Einschätzung
National Research Corp Aktie
Deutlicher Aufwärtstrend bei National Research Corp mit einem Gewinn von 1,38 % heute.
Was spricht für und gegen National Research Corp in den nächsten Jahren?
Pro
?
W******* i* V********
?
M****
?
L*********** I********** f** d** n******* J****
Kontra
?
U****************
?
A****************
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von National Research Corp im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| National Research Corp | 1,38 % | - | - | - | - | - | - |
| Newtek Business Services Inc. | -0,59 % | 4,85 % | 17,52 % | -23,95 % | -18,72 % | -42,42 % | - |
| Mistras Group Inc. | - | 3,55 % | -3,77 % | 21,43 % | 22,16 % | 25,93 % | 78,95 % |
| ICF International Inc. | 2,74 % | 4,17 % | 11,94 % | -36,44 % | -33,63 % | -24,24 % | 18,11 % |
Kommentare
News
NRC Health Announces Third Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2025.
“We delivered our
NRC Health Announces Shane Harrison as Chief Financial Officer
National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare experience, is pleased to announce the appointment of Shane Harrison as its
NRC Health Announces Second Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2025.
CEO Statement
Trent S. Green, Chief Executive Officer of NRC Health